Navigation Links
Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA
Date:2/21/2008

OSLO, February 21 /PRNewswire-FirstCall/ -- Algeta ASA (OSE: ALGETA), the cancer therapeutics company, today announced that it will shortly commence clinical development of Alpharadin(TM) in HRPC patients in the USA. Algeta filed its Investigational New Drug (IND) application for its lead product Alpharadin(TM) with the United States Food and Drug Administration (FDA) in December 2007. The statutory 30 day consultation period was extended by the FDA for a further 30 days by agreement with the company and the IND has now been cleared by the FDA without any objections being made to the application. Alpharadin(TM) has already been studied in phase II clinical trials in Europe and has demonstrated a potential for a significant survival benefit in hormone-refractory prostate cancer (HRPC) patients with skeletal metastases.

An initial Phase I pharmacokinetics, biodistribution and dosimetry study (BC1-08) with Alpharadin in HRPC patients with skeletal metastases will be conducted at the Memorial Sloan-Kettering Cancer Center in New York, one of the world's leading oncology centers. This US trial will further expand the information obtained in a similar phase I study (BC1-05) conducted at the Royal Marsden Hospital in London, for which patient enrolment has recently been completed.

Following the start up of the BC1-08 trial, Algeta will continue discussions with the FDA to agree on the design of the further clinical development program for Alpharadin(TM)

"We are delighted to have been given the clearance by FDA to advance Alpharadin into clinical development in the United States, and to be working with one of the world's leading cancer centers on our clinical program," said Dr. Thomas Ramdahl, President and CEO of Algeta. "There is a great unmet medical need among men suffering from HRPC with skeletal metastases and the opening of this US clinical trial will be an important step in our overall clinical development of Alpharadin. As earlier announ
'/>"/>

SOURCE Algeta
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-USNewswi...s medicine clinic in Los Angeles, has agreed to pa...ns that it received illegal kickbacks from HealthS... today. ,, The settlement resolves allegat...e in the form of stock option grants, donations to...
(Date:12/1/2009)...Even with equal care, very preterm births more lik...c. 1 (HealthDay News) -- Pregnant women who are po...than more affluent women, even though both groups ...shows. , The University of Leicester research t...e about the association between economic status an...
(Date:12/1/2009)... CAEAR Foundation Changes...ington, DC (Vocus) -- The CAEAR Foundation, one of..., is changing its name to HealthHIV and launching ...coincides with the start of a campaign to promote ...apabilities and reach. , , , , ,“HealthHIV ...
(Date:12/1/2009)..., , MEXICO CITY, Dec. 1 T...ll build a world-class center for biomedical and n... The center for medical research and development w...versity of Mexico, the top Spanish speaking univer...d to begin construction in 2010, has been designed...
(Date:12/1/2009)..., , SOUTHFIELD, Mich., Dec. 1 /PRNewswire-... (NYSE: FMR ) ("First Mercury" or the "Company"...ard of Directors declared a quarterly cash dividen...9 to shareholders of record at the close of busine...ury Financial Corporation ,, First Mercury Fin...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:More Preemies Born Among the Poor 2Health News:National HIV Non-Profit Announces New Name 2Health News:Mexico City to Build World-Class Hub for Medical Research 2
...Stereotaxis to Demonstrate Advanced Coronary & Per...Road Mapping at TCT 2007 Stereotaxis, Mob...ct. 19 Stereotaxis, Inc. (Nasdaq:,STXS) announced...cular Therapeutics (TCT) symposium in Washington,D...
...BATON ROUGE, La., Oct. 19 Amedisys, Inc.,(Nasdaq:...home health,nursing companies, today announced tha...the quarter ended September 30, 2007 pre-market on...in the conference call, please dial 800-683-1525,(...
...WASHINGTON, Oct. 18 The following statement,is at...: "The American Medical Association (AMA) welcome...ral Andrew Cuomo to issue a consumer warning,about...become more,informed purchasers of health care. Ac...
...Sing to Live Community Chorus: ,It Takes A Village...e-Live to Sing, a,not-for-profit organization foun...ished to create an all-voice community chorus to p...ival,provides its singers a venue to share their l...
...LIONVILLE, Pa., Oct. 18 West Pharmaceutical,Servi...lated to Pfizer,Inc.,s announcement that it has de...le Insulin product, returning the marketing rights...Nektar. "We were surprised and disappointed by Pf...
...DALLAS, Oct. 18 The National Association of,Denta...ation to collaborate,on reauthorization of the Chi...lly, NADP urges prompt action to enact the dental ...g key points:, -- Dental services should be a m...
Other Medicine News:Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 2Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 4Health News:Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results 2Health News:Breast Cancer Survivors and Their Supporters 'Sing to Live' 2Health News:West Pharmaceutical Services Issues Statement on Exubera 2Health News:West Pharmaceutical Services Issues Statement on Exubera 3Health News:West Pharmaceutical Services Issues Statement on Exubera 4Health News:NADP Calls on Congress and the White House to Work Together to Cover Children's Dental Health 2
(Date:12/1/2009)... , , LANSING, Mich., Dec. 1 /PRNewswire-Fi...nounced today that it has acquired the BioKits foo...robe Incorporated ( GPRO). The acquisition include...and fish speciation, and plant genetics. ,, Gen...cquisition of Tepnel Life Sciences plc in April 20...
(Date:12/1/2009)... , , BOTHELL, Wash., Dec. 1 /PRNewswir...D ) announced that on November 20, 2009 it license... Canada to manufacture and sell four extended rele...CDT® drug delivery platform. In addition, SC...two of such products in the United States on a non...
(Date:12/1/2009)... , , ATLANTA, Dec. 1 /PRNewswire-FirstCa...logical medical device and cardiovascular tissue p... guidance for 2010. ,, The Company expects tota... $118.0 million and $123.0 million, which includes...funding received from the Department of Defense in...
Breaking Medicine Technology:Neogen Acquires Gen-Probe's BioKits Food Safety Business 2SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 1Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 1Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 3Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 4Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 5Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 6Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 7Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 1Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 2
...07 /PRNewswire/ -- A new study suggests,strong var...e,northern and southern U.S. Anaphylaxis is a seve...atment with epinephrine. The,striking north-south ...phylaxis risk, currently are without explanation. ...evels of vitamin D,from lack of sunshine, may play...
...is, often conducted in a physicians office practic...array of ailments; UTIs, diabetes, several cancers...iseases. The estimated global market for urinalys...r and is growing strongly. For such a fundamental,...rocedure, the manufacturers of urinalysis analyzer...
Other Medicine Technology:Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3
Access Vitamin B12
...ANTA LiteTM ANA is an enzyme-linked immunosorbent ...of anti-nuclear antibodies (ANA) in human serum. T... clinical findings and other laboratory tests to a...systemic lupus erythematosus, Sjgren's syndrome, s...
...muno Concepts manufactures slides that are compati...technologist to decrease the number of pipetting s...ple dilutions on the slides. Ask Immuno Concepts f... slides. These slide formats are noted with an * a...
...e ANA and ENA assays can be used to screen out pat...re associated with various systemic rheumatic dise... Sjgren's syndrome, mixed connective tissue diseas...lymyositis, dermatomyositis, and Raynaud's phenome...
Medicine Products: